查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球核苷酸市场：成长、未来展望与竞争分析（2025-2033）
市场调查报告书
商品编码
1645245

全球核苷酸市场：成长、未来展望与竞争分析（2025-2033）

Nucleotide Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
出版日期: | 出版商: Acute Market Reports | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

核苷酸市场主要指核苷酸的商业化生产、分销和应用，核苷酸是构成 DNA 和 RNA 基本单位的有机分子。本质上，这些分子是生命的组成部分，在各种生物过程中发挥着非常重要的作用。2024年，市场将经历重大开放，主要推动力是遗传学、生物技术和製药领域的持续研究。除了用于基因研究之外，核苷酸还可用作食品和饮料的增味剂、增强免疫反应的膳食补充剂以及用于各种治疗用途的药物。预计2025年至2033年期间核苷酸市场年复合成长率为 6.9%。

驱动因素：基因研究与应用的蓬勃发展

过去十年，随着 CRISPR-Cas9 等基因编辑技术的进步，基因研究呈现爆炸性成长。这些技术进步需要稳定的核苷酸供应。例如，如果没有这些有机分子的稳定供应，目的是确定人类 DNA 中核苷酸碱基对序列的人类基因组计划就无法完成。此外，个人化医疗（根据个人基因组成製定治疗方案）的日益普及也进一步刺激了需求。这一趋势在癌症治疗中尤其明显，透过识别基因突变来确定最佳治疗方案。例如，识别与乳癌和卵巢癌风险相关的BRCA1 和 BRCA2 基因突变在很大程度上依赖核苷酸定序。

机会：营养保健食品和膳食补充剂的潜力

健康和保健产业转向天然和有机产品。越来越多的证据表明，核苷酸在改善肠道健康、增强免疫反应甚至加速剧烈运动后的恢復方面发挥着重要作用。 XYZ Health Boost 等品牌已开始将核苷酸添加到其膳食补充剂中，声称可以改善整体健康。此外，随着消费者对强化食品的认识和偏好不断增强，食品产业可能会利用核苷酸作为功能性食品和食品饮料中的有前景的成分。

障碍：道德问题与严格的法规

基因操作，即使用于治疗目的，也会引发各种伦理问题。这些问题包括对食品中基因改造生物（GMO）的担忧，以及遥远未来 "设计婴儿" 的想法。诸如此类的道德两难往往会导致严格的监管控制。例如欧盟对基因改造食品的严格管制，鑑于基因改造生物的作用，对核苷酸市场带来直接影响。此外，在德国和法国等国家，围绕基因改造作物的社会争论导致人们不愿意采用强化或改良核苷酸的食品。

挑战：核苷酸合成的技术限制

虽然需求成长，但生产纯净、无杂质的核苷酸在技术上仍然具有挑战性。目前的化学合成方法通常会产生所需异构体和不所需异构体的混合物，使纯化变得复杂。这不仅增加了生产成本，也影响了整体产量。 ABC Biotech 等公司报告指出，由于这些合成限制，扩大生产面临挑战，凸显了对更好的技术和製程的需求。

产品分析

根据产品细分，市场大致分为脱氧核苷酸、双脱氧核苷酸、RNA 合成核苷酸（rNTP）和标记核苷酸。从历史上看，脱氧核苷酸在2024年的销售额方面占据市场主导地位。这主要是因为它们在 DNA 复製和修復机制中发挥重要作用，而这对于基因研究和治疗应用非常重要。然而，用于 DNA 定序和萤光研究的标记核苷酸显示出最高的年复合成长率。定序技术和研究的需求激增预计将进一步推动标记核苷酸的成长，并可能使其成为未来十年的领导者。

技术分析

从技术面来看，市场分为 TaqMan 等位基因辨识、基因晶片/微阵列、焦磷酸定序的SNP 等。 TaqMan 等位基因鑑别技术以其特异性和效率而闻名，预计将在2024年带来最高收入。然而，可以同时研究多个基因的基因晶片/微阵列显示出最强的年复合成长率。随着基因组学时代的不断发展，高通量非常重要，预计基因晶片/微阵列将在2025年至2033年间获得显着的发展。

依地区分析

依地区划分，拥有技术先进的基础设施且在基因研究方面投入大量资金的北美预计将在2024年的销售方面处于领先地位。同时，以中国、印度等国家为首的亚太地区将呈现最强劲的年复合成长率，预计未来这一趋势仍将持续。该成长归因于该地区对生物技术研究的投资增加、认识的提高和医疗保健需求的激增。到2033年，鑑于亚太地区庞大的人口和日益普及的技术，该地区可能与北美并驾齐驱。

主要公司分析

在竞争方面，2024年的核苷酸市场将蓬勃发展，CJ CheilJedang Corp.、Star Lake Bioscience Co.、Thermo Fisher Scientific Inc.、MEIHUA HOLDINGS GROUP CO., LTD.、Biorigin、DSM Nutritional Products AG、Promega Corporation、Agilent Technologies Inc.、Lallemand Inc.、Nanjing Biotogether Co., Ltd.、NuEra Nutraceuticals Inc.和Ohly 开展併购和研究联盟，目的是扩大其产品组合併扩大其全球影响力。例如，AlphaGen Biotech 于2024年收购了 SeqWell Tech，在定序领域占据了显着优势。展望未来，预计2025年至2033年间占主导地位的策略包括与学术机构和研究团体的合作，以创新和生产具有成本效益、高效的核苷酸。

目录

第1章 简介

  • 分析内容
    • 分析目的
    • 目标受众
    • 主要产品
  • 市场区隔
  • 分析法
    • 第一阶段：二次研究
    • 第二阶段：初步调查
    • 第三阶段：专家评审
    • 先决条件
    • 所采取的方法

第2章 执行摘要

第3章 核苷酸市场：竞争分析

  • 主要供应商的市场定位
  • 供应商所采用的策略
  • 重大产业战略

第4章 核苷酸市场：宏观分析与市场动态

  • 简介
  • 全球核苷酸市场（价值，2023-2033年）
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 主要挑战
    • 主要机会
  • 驱动因素与限制因素影响分析
  • See-Saw分析
  • 波特五力模型
    • 供应商权力
    • 买方权力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争敌对
  • PESTEL 分析
    • 政治局势
    • 经济情势
    • 技术状况
    • 法律状况
    • 社会情势

第5章 核苷酸市场：依产品（2023-2033）

  • 市场概况
  • 成长与收入分析：2024年与2033年
  • 市场区隔
    • 脱氧核苷酸
      • 依製造方法
    • 双脱氧核苷酸
    • RNA合成核苷酸（rNTP）
    • 标记核苷酸

第6章 核苷酸市场：依技术（2023-2033）

  • 市场概况
  • 成长与收入分析：2024年与2033年
  • 市场区隔
    • TaqMan 等位基因鑑别
    • 基因晶片和微阵列
    • 透过焦磷酸定序进行 SNP
    • 其他

第7章 核苷酸市场：依应用（2023-2033）

  • 市场概况
  • 成长与收入分析：2024年与2033年
  • 市场区隔
    • 药品
    • 诊断与研究
    • 食品和饮料添加剂
    • 动物饲料添加剂
    • 其他

第8章 北美核苷酸市场（2023-2033）

  • 市场概况
  • 核苷酸市场：依产品（2023-2033）
  • 核苷酸市场：依技术（2023-2033）
  • 核苷酸市场：依应用（2023-2033）
  • 核苷酸市场：依地区（2023-2033）
    • 北美洲
      • 美国
      • 加拿大
      • 其他北美地区

第9章 英国与欧盟核苷酸市场（2023-2033）

  • 市场概况
  • 核苷酸市场：依产品（2023-2033）
  • 核苷酸市场：依技术（2023-2033）
  • 核苷酸市场：依应用（2023-2033）
  • 核苷酸市场：依地区（2023-2033）
    • 英国和欧盟国家
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 其他欧洲地区

第10章 亚太核苷酸市场（2023-2033）

  • 市场概况
  • 核苷酸市场：依产品（2023-2033）
  • 核苷酸市场：依技术（2023-2033）
  • 核苷酸市场：依应用（2023-2033）
  • 核苷酸市场：依地区（2023-2033）
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区

第11章 拉丁美洲核苷酸市场（2023-2033）

  • 市场概况
  • 核苷酸市场：依产品（2023-2033）
  • 核苷酸市场：依技术（2023-2033）
  • 核苷酸市场：依应用（2023-2033）
  • 核苷酸市场：依地区（2023-2033）
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第12章 中东与非洲核苷酸市场（2023-2033）

  • 市场概况
  • 核苷酸市场：依产品（2023-2033）
  • 核苷酸市场：依技术（2023-2033）
  • 核苷酸市场：依应用（2023-2033）
  • 核苷酸市场：依地区（2023-2033）
    • 中东和非洲
      • GCC
      • 非洲
      • 其他中东和非洲地区

第13章 公司简介

  • CJ CheilJedang Corp.
  • Star Lake Bioscience Co. Inc.
  • Thermo Fisher Scientific Inc.
  • MEIHUA HOLDINGS GROUP CO. LTD.
  • F. Hoffmann-La Roche Ltd.
  • Biorigin
  • DSM Nutritional Products AG
  • Promega Corporation
  • Agilent Technologies Inc.
  • Lallemand Inc.
  • Nanjing Biotogether Co. Ltd.
  • NuEra Nutraceuticals Inc.
  • Ohly
  • 其他
Product Code: 138-12-24

The nucleotide market primarily refers to the commercial production, distribution, and application of nucleotides, which are organic molecules forming the basic units of DNA and RNA. Essentially, these molecules are the building blocks of life, playing a vital role in various biological processes. In 2024, the market experienced significant developments, primarily fueled by the continued research in genetics, biotechnology, and pharmaceuticals. Nucleotides are not only used in genetic research but also find applications in food and beverages as flavor enhancers, in dietary supplements for enhancing immune response, and in pharmaceuticals for various treatments. Nucleotide market is estimated to grow at a CAGR of 6.9% from 2025 to 2033.

Driver: Booming Genetic Research and Applications

The past decade saw a surge in genetic research, with advancements in gene editing technologies like CRISPR-Cas9. These innovations necessitated a steady supply of nucleotides. For instance, the Human Genome Project, which aimed to determine the sequence of nucleotide base pairs in human DNA, could not have been completed without a steady supply of these organic molecules. Moreover, the increasing adoption of personalized medicine, where treatments are tailored based on individual genetic makeup, further drove demand. This trend is evident in cancer treatments where genetic mutations are identified to determine the best course of action. For example, the identification of BRCA1 and BRCA2 gene mutations, which are linked to breast and ovarian cancer risks, rely heavily on nucleotide sequencing.

Opportunity: Potential in Dietary Supplements and Nutraceuticals

The health and wellness industry is witnessing a shift towards natural and organic products. There's growing evidence suggesting nucleotides can play a pivotal role in improving gut health, enhancing immune response, and even aiding quicker recovery post high-intensity workouts. Brands like "XYZ Health Boost" have started incorporating nucleotides in their dietary supplements, claiming improved overall health. Furthermore, with the increasing consumer awareness and preference for fortified foods, the food industry could harness nucleotides as a promising ingredient in functional foods and beverages.

Restraint: Ethical Concerns and Regulatory Stringency

The manipulation of genes, even for therapeutic purposes, brings forth various ethical issues. These range from concerns about genetically modified organisms (GMOs) in food to the idea of 'designer babies' in the far future. Such ethical dilemmas often lead to strict regulatory controls. For instance, the European Union's stringent regulations on GMO foods directly impact the nucleotide market, considering their role in genetically modifying organisms. Additionally, in countries like Germany and France, the public debate around GMOs has led to hesitancy in adopting foods enhanced or modified with nucleotides.

Challenge: Technical Limitations in Nucleotide Synthesis

While the demand is rising, producing nucleotides in their pure, unadulterated form remains technically challenging. The current chemical synthesis methods often result in a mix of desired and undesired isomers, making purification complex. This not only increases production costs but also affects the overall yield. Companies like "ABC Biotech" have reported challenges in scaling up their production due to these synthesis limitations, emphasizing the need for better technologies and processes.

Product Insights

In the product division, the market largely bifurcates into Deoxy Nucleotides, Dideoxynucleotides, Nucleotides for RNA Synthesis (rNTP), and Labelled Nucleotides. Historically, Deoxy Nucleotides had dominated the market in terms of revenue in 2024, largely due to their essential role in DNA replication and repair mechanisms, making them fundamental in genetic research and therapeutic applications. However, Labelled Nucleotides, with their application in DNA sequencing and fluorescence studies, exhibited the highest CAGR. The burgeoning demand for sequencing techniques and research is expected to further propel the growth of Labelled Nucleotides, marking them as the likely frontrunners for the upcoming decade.

Technology Insights

From a technological perspective, the market categorization comprises TaqMan Allelic Discrimination, Gene Chips & Microarrays, SNP By Pyrosequencing, among others. The TaqMan Allelic Discrimination technique, renowned for its specificity and efficiency, accounted for the highest revenue in 2024. Nevertheless, Gene Chips & Microarrays, given their capability to study several genes simultaneously, showcased the most robust CAGR. With the expanding genomics era, where high throughput is essential, Gene Chips & Microarrays are anticipated to gain substantial traction in the period between 2025 and 2033.

Regional Insights

Geographically, North America, with its technologically advanced infrastructure and substantial funding in genetic research, reigned supreme in revenue generation in 2024. Concurrently, Asia-Pacific, powered by nations like China and India, displayed the steepest CAGR, a trend expected to persist. This uptick can be attributed to the increasing investment in biotechnological research, growing awareness, and burgeoning healthcare needs in the region. By 2033, Asia-Pacific might well compete neck-to-neck with North America, considering its vast population and growing technological adoption.

Analysis of Key Players

On the competitive front, the Nucleotide Market, in 2024, saw robust strategies employed by key players such as CJ CheilJedang Corp., Star Lake Bioscience Co., Inc., Thermo Fisher Scientific Inc., MEIHUA HOLDINGS GROUP CO., LTD., F. Hoffmann-La Roche Ltd., Biorigin, DSM Nutritional Products AG, Promega Corporation, Agilent Technologies Inc., Lallemand Inc., Nanjing Biotogether Co., Ltd., NuEra Nutraceuticals Inc., Ohly Mergers, acquisitions, and research partnerships were rampant, aiming to broaden the product portfolio and expand global footprints. For instance, "AlphaGen Biotech's" acquisition of "SeqWell Tech" in 2024 allowed them a significant edge in the sequencing domain. Moving forward, the strategy likely to be dominant from 2025 to 2033 involves collaboration with academic institutions and research entities to innovate and produce cost-effective, high-efficiency nucleotides.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Nucleotide market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Nucleotide market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Product
    • Deoxy Nucleotides
  • By Production Method
  • Enzyme Sourced
  • Chemical Synthesis
    • Dideoxynucleotides
    • Nucleotides for RNA Synthesis (rNTP)
    • Labelled Nucleotides
  • Technology
    • TaqMan Allelic Discrimination
    • Gene Chips & Microarrays
    • SNP By Pyrosequencing
    • Others
  • Application
    • Pharmaceuticals
    • Diagnostics Research
    • Food & Beverage Additive
    • Animal Feed Additive
    • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Nucleotide market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Nucleotide market?
  • Which is the largest regional market for Nucleotide market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Nucleotide market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Nucleotide market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nucleotide Market
  • 2.2. Global Nucleotide Market, By Product, 2024 (US$ Million)
  • 2.3. Global Nucleotide Market, By Technology, 2024 (US$ Million)
  • 2.4. Global Nucleotide Market, By Application, 2024 (US$ Million)
  • 2.5. Global Nucleotide Market, By Geography, 2024 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2024

3. Nucleotide Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nucleotide Market Vendors
  • 3.2. Strategies Adopted by Nucleotide Market Vendors
  • 3.3. Key Industry Strategies

4. Nucleotide Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nucleotide Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Nucleotide Market: By Product, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Deoxy Nucleotides
      • 5.3.1.1. By Production Method
        • 5.3.1.1.1. Enzyme Sourced
        • 5.3.1.1.2. Chemical Synthesis
    • 5.3.2. Dideoxynucleotides
    • 5.3.3. Nucleotides for RNA Synthesis (rNTP)
    • 5.3.4. Labelled Nucleotides

6. Nucleotide Market: By Technology, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. TaqMan Allelic Discrimination
    • 6.3.2. Gene Chips & Microarrays
    • 6.3.3. SNP By Pyrosequencing
    • 6.3.4. Others

7. Nucleotide Market: By Application, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 7.3. Market Segmentation
    • 7.3.1. Pharmaceuticals
    • 7.3.2. Diagnostics Research
    • 7.3.3. Food & Beverage Additive
    • 7.3.4. Animal Feed Additive
    • 7.3.5. Others

8. North America Nucleotide Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nucleotide Market: By Product, 2023-2033, USD (Million)
  • 8.3. Nucleotide Market: By Technology, 2023-2033, USD (Million)
  • 8.4. Nucleotide Market: By Application, 2023-2033, USD (Million)
  • 8.5.Nucleotide Market: By Region, 2023-2033, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 8.5.1.1.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.1.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 8.5.1.2.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.2.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 8.5.1.3.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 8.5.1.3.3. Nucleotide Market: By Application, 2023-2033, USD (Million)

9. UK and European Union Nucleotide Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nucleotide Market: By Product, 2023-2033, USD (Million)
  • 9.3. Nucleotide Market: By Technology, 2023-2033, USD (Million)
  • 9.4. Nucleotide Market: By Application, 2023-2033, USD (Million)
  • 9.5.Nucleotide Market: By Region, 2023-2033, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.1.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.1.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.2.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.2.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.3.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.3.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.4.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.4.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.5.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.5.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 9.5.1.6.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 9.5.1.6.3. Nucleotide Market: By Application, 2023-2033, USD (Million)

10. Asia Pacific Nucleotide Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nucleotide Market: By Product, 2023-2033, USD (Million)
  • 10.3. Nucleotide Market: By Technology, 2023-2033, USD (Million)
  • 10.4. Nucleotide Market: By Application, 2023-2033, USD (Million)
  • 10.5.Nucleotide Market: By Region, 2023-2033, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.1.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.1.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.2.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.2.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.3.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.3.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.4.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.4.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.5.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.5.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 10.5.1.6.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 10.5.1.6.3. Nucleotide Market: By Application, 2023-2033, USD (Million)

11. Latin America Nucleotide Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nucleotide Market: By Product, 2023-2033, USD (Million)
  • 11.3. Nucleotide Market: By Technology, 2023-2033, USD (Million)
  • 11.4. Nucleotide Market: By Application, 2023-2033, USD (Million)
  • 11.5.Nucleotide Market: By Region, 2023-2033, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 11.5.1.1.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.1.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 11.5.1.2.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.2.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 11.5.1.3.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 11.5.1.3.3. Nucleotide Market: By Application, 2023-2033, USD (Million)

12. Middle East and Africa Nucleotide Market, 2023-2033, USD (Million)

  • 12.1. Market Overview
  • 12.2. Nucleotide Market: By Product, 2023-2033, USD (Million)
  • 12.3. Nucleotide Market: By Technology, 2023-2033, USD (Million)
  • 12.4. Nucleotide Market: By Application, 2023-2033, USD (Million)
  • 12.5.Nucleotide Market: By Region, 2023-2033, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 12.5.1.1.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.1.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 12.5.1.2.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.2.3. Nucleotide Market: By Application, 2023-2033, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Nucleotide Market: By Product, 2023-2033, USD (Million)
        • 12.5.1.3.2. Nucleotide Market: By Technology, 2023-2033, USD (Million)
        • 12.5.1.3.3. Nucleotide Market: By Application, 2023-2033, USD (Million)

13. Company Profile

  • 13.1. CJ CheilJedang Corp.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Star Lake Bioscience Co., Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. MEIHUA HOLDINGS GROUP CO., LTD.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. F. Hoffmann-La Roche Ltd.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Biorigin
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. DSM Nutritional Products AG
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Promega Corporation
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Agilent Technologies Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Lallemand Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Nanjing Biotogether Co., Ltd.
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. NuEra Nutraceuticals Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Ohly
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. Others
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 2 Global Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 3 Global Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 4 Global Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 5 Global Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 6 North America Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 7 North America Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 8 North America Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 9 North America Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 10 North America Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 11 U.S. Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 12 U.S. Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 13 U.S. Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 14 U.S. Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 15 U.S. Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 16 Canada Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 17 Canada Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 18 Canada Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 19 Canada Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 20 Canada Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 21 Rest of North America Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 22 Rest of North America Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 23 Rest of North America Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 24 Rest of North America Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 25 Rest of North America Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 26 UK and European Union Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 27 UK and European Union Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 28 UK and European Union Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 29 UK and European Union Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 30 UK and European Union Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 31 UK Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 32 UK Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 33 UK Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 34 UK Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 35 UK Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 36 Germany Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 37 Germany Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 38 Germany Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 39 Germany Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 40 Germany Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 41 Spain Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 42 Spain Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 43 Spain Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 44 Spain Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 45 Spain Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 46 Italy Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 47 Italy Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 48 Italy Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 49 Italy Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 50 Italy Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 51 France Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 52 France Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 53 France Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 54 France Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 55 France Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 56 Rest of Europe Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 57 Rest of Europe Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 58 Rest of Europe Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 59 Rest of Europe Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 60 Rest of Europe Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 61 Asia Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 62 Asia Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 63 Asia Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 64 Asia Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 65 Asia Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 66 China Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 67 China Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 68 China Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 69 China Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 70 China Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 71 Japan Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 72 Japan Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 73 Japan Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 74 Japan Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 75 Japan Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 76 India Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 77 India Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 78 India Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 79 India Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 80 India Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 81 Australia Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 82 Australia Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 83 Australia Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 84 Australia Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 85 Australia Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 86 South Korea Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 87 South Korea Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 88 South Korea Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 89 South Korea Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 90 South Korea Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 91 Latin America Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 92 Latin America Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 93 Latin America Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 94 Latin America Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 95 Latin America Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 96 Brazil Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 97 Brazil Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 98 Brazil Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 99 Brazil Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 100 Brazil Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 101 Mexico Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 102 Mexico Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 103 Mexico Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 104 Mexico Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 105 Mexico Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 106 Rest of Latin America Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 107 Rest of Latin America Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 108 Rest of Latin America Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 109 Rest of Latin America Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 110 Rest of Latin America Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 111 Middle East and Africa Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 112 Middle East and Africa Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 113 Middle East and Africa Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 114 Middle East and Africa Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 115 Middle East and Africa Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 116 GCC Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 117 GCC Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 118 GCC Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 119 GCC Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 120 GCC Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 121 Africa Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 122 Africa Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 123 Africa Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 124 Africa Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 125 Africa Nucleotide Market By Application, 2023-2033, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Nucleotide Market By Product, 2023-2033, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Nucleotide Market By Deoxy Nucleotides, 2023-2033, USD (Million)
  • TABLE 128 Rest of Middle East and Africa Nucleotide Market By By Production Method, 2023-2033, USD (Million)
  • TABLE 129 Rest of Middle East and Africa Nucleotide Market By Technology, 2023-2033, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Nucleotide Market By Application, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global Nucleotide Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nucleotide Market: Quality Assurance
  • FIG. 5 Global Nucleotide Market, By Product, 2024
  • FIG. 6 Global Nucleotide Market, By Technology, 2024
  • FIG. 7 Global Nucleotide Market, By Application, 2024
  • FIG. 8 Global Nucleotide Market, By Geography, 2024
  • FIG. 9 Market Geographical Opportunity Matrix - Global Nucleotide Market, 2024
  • FIG. 10Market Positioning of Key Nucleotide Market Players, 2024
  • FIG. 11 Global Nucleotide Market, By Product, 2024 Vs 2033, %
  • FIG. 12 Global Nucleotide Market, By Technology, 2024 Vs 2033, %
  • FIG. 13 Global Nucleotide Market, By Application, 2024 Vs 2033, %